Sézary Syndrome-Eosinophilia Explained by a Blood Film. [PDF]
Am J HematolAmerican Journal of Hematology, Volume 100, Issue 8, Page 1423-1424, August 2025.
Soeterik MTA +5 more
europepmc +2 more sources
HDAC10 and its implications in Sézary syndrome pathogenesis [PDF]
Frontiers in Cell and Developmental BiologyCutaneous T-cell lymphomas (CTCL) are a group of rare hematological malignancies characterized by infiltration of malignant T-cells into the skin. Two main types of CTCL constitute of Mycosis Fungoides (MF), a more indolent form of the disease, and ...
Monika Pieniawska +17 more
doaj +2 more sources
Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome
Acta Dermato-Venereologica, 2019 Tumor cells in cutaneous T-cell lymphoma express limited numbers of chemokine receptors. We investigated the expression patterns of CXCR3, CCR3, CCR4 and CCR10 in mycosis fungoides, Sézary syndrome, lymphomatoid papulosis and anaplastic large cell ...
Yuki Shono +8 more
doaj +3 more sources
Bilateral peripheral ulcerative keratitis in a patient with known Sézary syndrome [PDF]
American Journal of Ophthalmology Case ReportsPurpose: To report a case of bilateral peripheral ulcerative keratitis (PUK) in a patient with underlying Sézary syndrome. Observations: A 58-year-old male presented with bilateral corneal ulceration with stromal thinning and was diagnosed with PUK.
Michael J. Maywood +2 more
doaj +2 more sources
Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors [PDF]
Frontiers in Immunology, 2023 Mycosis fungoides (MF) and Sézary syndrome (SS) are forms of cutaneous T cell lymphoma (CTCL) that pose significant challenges in their clinical management, particularly in refractory and advanced-stage disease.
Iman Quadri +4 more
doaj +2 more sources
Low SATB1 Expression Promotes IL-5 and IL-9 Expression in Sézary Syndrome [PDF]
Journal of Investigative Dermatology, 2020 Terkild B. Buus +22 more
openaire +5 more sources
Peripheral Neuropathy in Sézary Syndrome: Coincidence or a Part of the Syndrome?
Turkish Journal of Hematology, 2013 Yeşim S. Karadağ +4 more
doaj +2 more sources
Mycosis fungoides and Sézary syndrome
healthbook TIMES. Oncology Hematology, 2021 Mycosis fungoides (MF) and Sézary syndrome (SS) are two subgroups of cutaneous T-cell lymphomas (CTCL), which belong to the extranodal non-Hodgkin lymphomas. These are rare diseases whose etiology is still not fully understood.
Ieva Saulite +2 more
doaj +2 more sources
OncoImmunology, 2022 The PD-1 inhibitor pembrolizumab is effective in treating Sézary syndrome, a leukemic variant of cutaneous T-cell lymphoma. Our purpose was to investigate the effects of pembrolizumab on healthy and malignant T cells in Sézary syndrome and to discover ...
Tianying Su +6 more
doaj +1 more source
Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome [PDF]
Journal for ImmunoTherapy of Cancer, 2019 Cutaneous squamous cell carcinoma (cSCC) is not uncommon in association with indolent malignancies that were treated with prior radiotherapy and after allogenic bone marrow transplantation. On the other hand, cutaneous T-cell lymphoma (CTCL) is a subtype of non-Hodgkin's lymphoma which is characterized by an indolent course, with relative ...
Karam Khaddour +6 more
openaire +5 more sources